Advances in Molecular OncologyAdvances in Molecular OncologyУспехи молекулярной онкологии2313-805X2413-3787Publishing House ABV Press5410.17650/2313-805X.2016.3.1.44-52RESEARCH ARTICLESЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИImprovement of accuracy and diagnostic significance of breast tumor fine-needle aspiration biopsy by miRNA analysis of material isolated from cytological smearsПовышение точности и информативности тонкоигольной аспирационной пункционной биопсии опухолей молочной железы путем анализа микроРНК в материале цитологического мазкаKolesnikovN. N.КолесниковН. Н.
Russian Federation

8/2 Acad. Lavrentyevа prospekt, Novosibirsk, 630090

630090, Новосибирск, просп. Акад. Лаврентьева, 8/2

TitovS. E.ТитовС. Е.
Russian Federation

8/2 Acad. Lavrentyevа prospekt, Novosibirsk, 630090;

Novosibirsk-117, 630117

630090, Новосибирск, просп. Акад. Лаврентьева, 8/2;

630117, Новосибирск-117

VeryaskinaYu. A.ВеряскинаЮ. А.
Russian Federation

8/2 Acad. Lavrentyevа prospekt, Novosibirsk, 630090

630090, Новосибирск, просп. Акад. Лаврентьева, 8/2

VladimirovaA. V.ВладимироваА. В.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

SamsonovR. B.СамсоновР. Б.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758;

11 Khoshimina St., Saint Petersburg, 194356

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68;

194356, Санкт-Петербург, ул. Хошимина, 11

Artem’evaA. S.АртемьеваА. С.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

NovikV. I.НовикВ. И.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

BershteynL. M.БерштейнЛ. М.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68

ZhimulevI. F.ЖимулевИ. Ф.
Russian Federation

8/2 Acad. Lavrentyevа prospekt, Novosibirsk, 630090

630090, Новосибирск, просп. Акад. Лаврентьева, 8/2

MalekA. V.MалекА. В.
Russian Federation

68 Leningradskaya St., Pesochnyi Settlement, Saint Petersburg, 197758;

11 Khoshimina St., Saint Petersburg, 194356

197758, Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68;

194356, Санкт-Петербург, ул. Хошимина, 11

anastasia@malek.comInstitute of Molecular and Cellular Biology, Siberian Branch, Russian Academy of SciencesФГБУН «Институт молекулярной и клеточной биологии» Сибирского отделения РАНZAO “West-Best”ЗАО «Вектор-Бест»N.N. Petrov Research Institute of Oncology, Ministry of Health of RussiaФГБУ «Научно-исследовательский институт онкологии им. Н.Н. Петрова» Минздрава РоссииООО “Onkosystema”ООО «Онкосистема»150120163144522504201625042016Copyright ©; 2016, Kolesnikov N.N., Titov S.E., Veryaskina Y.A., Vladimirova A.V., Samsonov R.B., Artem’eva A.S., Novik V.I., Bershteyn L.M., Zhimulev I.F., Malek A.V.Copyright ©; 2016, Колесников Н.Н., Титов С.Е., Веряскина Ю.А., Владимирова А.В., Самсонов Р.Б., Артемьева А.С., Новик В.И., Берштейн Л.М., Жимулев И.Ф., Mалек А.В.2016Kolesnikov N.N., Titov S.E., Veryaskina Y.A., Vladimirova A.V., Samsonov R.B., Artem’eva A.S., Novik V.I., Bershteyn L.M., Zhimulev I.F., Malek A.V.Колесников Н.Н., Титов С.Е., Веряскина Ю.А., Владимирова А.В., Самсонов Р.Б., Артемьева А.С., Новик В.И., Берштейн Л.М., Жимулев И.Ф., Mалек А.В.https://creativecommons.org/licenses/by/4.0https://umo.abvpress.ru/jour/article/view/54

breast cancerdiagnosticsfine needle aspiration biopsymicroRNAmiR-125bрак молочной железыдиагностикатонкоигольная аспирационная пункционная биопсиямикроРНКмиРНК-125b1. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена»Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2012 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена»Минздрава России, 2014. [Kaprin А.D., Starinskiy V.V., Petrovа G.V. Malignant neoplasms in Russia in 2012 (morbidity and fatality). Мoscow: P.A. Herzen Moscow Cancer Research Institute, Ministry of Health of Russia, 2014. (In Russ.)].2. Stolier A., Skinner J., Levine E.A. A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg 2000;180(2):104–7.Stolier A., Skinner J., Levine E.A. A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg 2000;180(2):104–7.3. Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu Rev Pathol 2014;9:287–314.Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu Rev Pathol 2014;9:287–314.4. Kolesnikov N.N., Titov S.E., Veriaskina Iu.A. et al. MicroRNA, evolution and cancer. Tsitologiia 2013;55(3):159–64.Kolesnikov N.N., Titov S.E., Veriaskina Iu.A. et al. MicroRNA, evolution and cancer. Tsitologiia 2013;55(3):159–64.5. Takahashi R.U., Miyazaki H., Ochiya T. The Roles of MicroRNAs in Breast Cancer. Cancers 2015;7(2):598–616.Takahashi R.U., Miyazaki H., Ochiya T. The Roles of MicroRNAs in Breast Cancer. Cancers 2015;7(2):598–616.6. Bertoli G., Cava C., Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics 2015;5(10):1122–43.Bertoli G., Cava C., Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics 2015;5(10):1122–43.7. Graveel C.R., Calderone H.M., Westerhuis J.J. et al. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer 2015;7:59–79.Graveel C.R., Calderone H.M., Westerhuis J.J. et al. Critical analysis of the potential for microRNA biomarkers in breast cancer management. Breast Cancer 2015;7:59–79.8. Bhattacharyya M., Nath J., Bandyopadhyay S. MicroRNA signatures highlight new breast cancer subtypes. Gene 2015;556(2):192–8.Bhattacharyya M., Nath J., Bandyopadhyay S. MicroRNA signatures highlight new breast cancer subtypes. Gene 2015;556(2):192–8.9. Веряскина Ю.А., Титов С.Е., Родионов В.В. др. Экспрессия микроРНК в молекулярно-генетических подтипах рака молочной железы. Современные проблемы науки и образования 2015;5. [Veryaskinа Yu.А., Тitov S.Е., Rodionov V.V. et al. MicroRNA experssion in molecular & genetic subtype of the mammary gland cancer. Sovremennye problemy nauki i obrazovaniya = Modern Science and Education Problems 2015;5. (In Russ.)].Веряскина Ю.А., Титов С.Е., Родионов В.В. др. Экспрессия микроРНК в молекулярно-генетических подтипах рака молочной железы. Современные проблемы науки и образования 2015;5. [Veryaskinа Yu.А., Тitov S.Е., Rodionov V.V. et al. MicroRNA experssion in molecular & genetic subtype of the mammary gland cancer. Sovremennye problemy nauki i obrazovaniya = Modern Science and Education Problems 2015;5. (In Russ.)].10. Gasparini P., Cascione L., Fassan M. et al. MicroRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 2014;5(5):1174–84.Gasparini P., Cascione L., Fassan M. et al. MicroRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 2014;5(5):1174–84.11. Kolacinska A., Morawiec J., Fendler W. et al. Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report. Mol Biol Rep 2014;41(5):2851–7.Kolacinska A., Morawiec J., Fendler W. et al. Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report. Mol Biol Rep 2014;41(5):2851–7.12. Ouyang M., Li Y., Ye S. et al. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PloS One 2014;9(5):e96228.Ouyang M., Li Y., Ye S. et al. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PloS One 2014;9(5):e96228.13. Harquail J., Benzina S., Robichaud G.A. MicroRNAs and breast cancer malignancy: an overview of miRNAregulated cancer processes leading to metastasis. Cancer Biomark 2012;11(6):269–80.Harquail J., Benzina S., Robichaud G.A. MicroRNAs and breast cancer malignancy: an overview of miRNAregulated cancer processes leading to metastasis. Cancer Biomark 2012;11(6):269–80.14. Tanic M., Yanowski K., Andres E. et al. MiRNA expression profiling of formalinfixed paraffin-embedded (FFPE) hereditary breast tumors. Genom Data 2015;3:75–9.Tanic M., Yanowski K., Andres E. et al. MiRNA expression profiling of formalinfixed paraffin-embedded (FFPE) hereditary breast tumors. Genom Data 2015;3:75–9.15. Kolacinska A., Morawiec J., Pawlowska Z. et al. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients. DNA Cell Biol 2014;33(9):624–9.Kolacinska A., Morawiec J., Pawlowska Z. et al. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients. DNA Cell Biol 2014;33(9):624–9.16. Phuong N.T., Kim S.K., Im J.H. et al. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells. Oncotarget 2015.Phuong N.T., Kim S.K., Im J.H. et al. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells. Oncotarget 2015.17. Calvano Filho C.M., Calvano-Mendes D.C., Carvalho K.C. et al. Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR- 17-5p, and miR-20a-5p. Tumour Biology 2014;35(8):7733–41.Calvano Filho C.M., Calvano-Mendes D.C., Carvalho K.C. et al. Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR- 17-5p, and miR-20a-5p. Tumour Biology 2014;35(8):7733–41.18. Xu F., He H., Huang W. et al. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Clin Transl Oncol 2016;18(3):283–8.Xu F., He H., Huang W. et al. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Clin Transl Oncol 2016;18(3):283–8.19. Tsouko E., Wang J., Frigo D.E. et al. MiR-200a inhibits migration of triplenegative breast cancer cells through direct repression of the EPHA2 oncogene. Carcinogenesis 2015;36(9):1051–60.Tsouko E., Wang J., Frigo D.E. et al. MiR-200a inhibits migration of triplenegative breast cancer cells through direct repression of the EPHA2 oncogene. Carcinogenesis 2015;36(9):1051–60.20. Usmani A., Shoro A.A., Memon Z. et al. Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals. Am J Cancer Res 2015;5(8):2484–90.Usmani A., Shoro A.A., Memon Z. et al. Diagnostic, prognostic and predictive value of MicroRNA-21 in breast cancer patients, their daughters and healthy individuals. Am J Cancer Res 2015;5(8):2484–90.21. Eissa S., Matboli M., Sharawy A., El-Sharkawi F. Prognostic and biological significance of microRNA-221 in breast cancer. Gene 2015;574(1):163–7.Eissa S., Matboli M., Sharawy A., El-Sharkawi F. Prognostic and biological significance of microRNA-221 in breast cancer. Gene 2015;574(1):163–7.22. Li Y., Liang C., Ma H. et al. MiR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. Molecules 2014;19(6):7122–37.Li Y., Liang C., Ma H. et al. MiR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer. Molecules 2014;19(6):7122–37.23. Yu D.D., Lv M.M., Chen W.X. et al. Role of miR-155 in drug resistance of breast cancer. Tumour Biol 2015;36(3):1395–401.Yu D.D., Lv M.M., Chen W.X. et al. Role of miR-155 in drug resistance of breast cancer. Tumour Biol 2015;36(3):1395–401.24. Zhang H., Fan Q. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression. Oncol Rep 2015;34(4):2163–70.Zhang H., Fan Q. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression. Oncol Rep 2015;34(4):2163–70.25. Vilquin P., Donini C.F., Villedieu M. et al. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Breast Cancer Res 2015;17:13.Vilquin P., Donini C.F., Villedieu M. et al. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer. Breast Cancer Res 2015;17:13.26. Hurst D.R., Edmonds M.D., Scott G.K. et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009;69(4):1279–83.Hurst D.R., Edmonds M.D., Scott G.K. et al. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 2009;69(4):1279–83.